CXCR4 expression, a G-protein coupled receptor involved in the epithelial-to-mesenchymal transition (EMT) and cancer stem cell survival, was correlated, in GBM tumors, with a state of progression and therapy resistance [76]. The gene discussed is CXCR4; the disease is cancer.